OR WAIT null SECS
August 21, 2019
Pfizer is investing $500 million for the construction of a state-of-the-art gene therapy manufacturing facility in Sanford, NC.
August 14, 2019
The companies have entered into a manufacturing agreement for the production of Phase III clinical trial material.
August 13, 2019
AskBio’s acquisition of Synpromics will improve the efficacy of its adeno-associated virus gene therapy vectors.
August 12, 2019
The acquisition strengthens BioLife’s position as a supplier of disruptive, enabling solutions used for manufacturing, storage, and distribution of cell and gene therapies.
August 09, 2019
The acquisition will boost Bayer’s cell-therapy development programs, with an initial focus on neurology, cardiology, and immunology.
The facility will support gene therapy production and continued development of PTC’s pipeline of investigational medicines.
August 01, 2019
Now that the first genetically modified cell therapies are being manufactured, the industry must move beyond “whatever works” to meet growing demand.
Biopharma industry faces production challenges as gene therapies move from clinical to commercialization.
Mass-produce cell and gene therapies presents the biopharma industry with a unique set of challenges.
Researchers in China are playing a role in advancing gene therapy development.